Shanghai-based Ailibi Information Technology, developer of mobile kidney healthcare information platform "Aishen" (literally "Love Kidney"), has completed RMB 8-digit Series A funding led by Morningside Ventures, with participation from Yunxi (Beijing) Investment Fund Management. The funding will be used to continue expansion of the company's network of offline kidney dialysis centers.
The company is currently comprised mainly of its online Aishen platform and offline chain of dialysis centers, specializing in providing patients with complete medical treatment services from chronic disease management to dialysis treatment. Aishen provides kidney disease sufferers with kidney disease-related news and nutrition management services.
After establishing a kidney disease specialist hospital in Hainan Province's capital of Haikou, Aishen will focus on expanding to second- and third-tier cities, providing comprehensive kidney disease services. Construction has begun on a dialysis center in Sanya, a city in Hainan, and dialysis centers in other provinces are undergoing approval or are still in the preparation stages.
Editor's Note: For more background on Aishen, please see "Mobile Kidney Healthcare Platform 'Aishen' Lands RMB 8-digit Pre-A," MD 10/08/16 issue.